Brief: Oruka Therapeutics Announces Pricing Of Upsized $700 Million Underwritten Public Offering
29/04/2026 24:44
April 28 (Reuters) - Oruka Therapeutics Inc ORKA.O: ORUKA THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $700 MILLION UNDERWRITTEN PUBLIC OFFERING ORUKA THERAPEUTICS INC - PRICES UPSIZED OFFERING OF 9,660,000 SHARES AT $72.50 PER SHARE ORUKA THERAPEUTICS INC - EXPECTS GROSS PROCEEDS OF $700.4 MILLION FROM OFFERING Source text: ID:nGNX7QHhLf Further company coverage: ORKA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oruka Therapeutics
See all newsOruka falls after reporting mid-stage data for psoriasis drug
Brief: Oruka Therapeutics Announces Positive Week 28 Data For Orka-001 From The Ongoing Everlast-A Trial Showing Deepening Of Responses Without Additional Dosing
Brief: Oruka Therapeutics Appoints Todd Edwards As Chief Commercial Officer
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Oruka Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary